Diagnosis of systemic amyloidosis

N.V. Ponich, О.V. Stupak, О.А. Epanchintseva, О.J. Zharinov

References

1. Abdelmoneim S.S., Bernier M., Bellavia D. et al. Myocardial contrast echocardiography in biopsy-proven primary cardiac amyloidosis // Eur. J. Echocard.– 2008.– Vol. 9.– P. 338–341.

2. Koyama J., Ray-Sequin P.A., Davidoff R. et al. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis // Amer. J. Cardiol.– 2002.– Vol. 89.– P. 1067–1071.

3. Ozdemir B.H., Ozdemir F.N., Sezer S. et al. Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis // Transplant. Proc.– 2006.– Vol. 38.– P. 432–434.

4. Falka R.H., Dubreyb S.W. Amyloid heart disease // Progress Cardiovasc. Dis.– 2010.– Vol. 52.– P. 347–361.

5. Damy T., Plante-Bordeneuve V., Valleix S. Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene // Arch. Cardiovasc. Dis.– 2012.– Vol. 105.– P. 614–615.